Literature DB >> 17544251

The international conference on malignant bowel obstruction: a meeting of the minds to advance palliative care research.

Robert S Krouse1.   

Abstract

There is a dearth of well-designed clinical research focusing on palliative care in cancer patients, especially those who are near the end of life. Reasons for this include ethical dilemmas in conducting such trials, communication barriers between specialties, and unclear standards for best care practices. To ensure that patients with incurable illnesses are offered the best available care, it is essential to develop and disseminate research methodologies well suited to this population. Given the multidimensional and culture-dependent nature of the end-of-life experience, it is necessary to adopt an interdisciplinary approach to developing research methods. As a means of initiating the process of palliative clinical research methodology development, malignant bowel obstruction (MBO) was used as a model to develop a research protocol. Although many treatment options for MBO have been proposed, existing literature offers little guidance with regard to algorithms for optimal management. To this end, an international leaders in quality-of-life research, ethnocultural variability, palliative medicine, surgical oncology, gastroenterology, major consortium research, medical ethics, and patient advocacy/cancer survivors was convened in Pasadena, California, on November 12-13, 2004. Participants also represented the broad ethnic and racial perspectives required to develop culturally sensitive research methods. Consensus on methodological approaches was attained through vigorous debate. Using the conference-developed MBO model to implement trials will advance palliative care research.

Entities:  

Mesh:

Year:  2007        PMID: 17544251      PMCID: PMC2834265          DOI: 10.1016/j.jpainsymman.2007.04.005

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  14 in total

1.  Measuring quality of care at life's end.

Authors:  I R Byock; J M Teno; M J Field
Journal:  J Pain Symptom Manage       Date:  1999-02       Impact factor: 3.612

2.  When the sun can set on an unoperated bowel obstruction: management of malignant bowel obstruction.

Authors:  Robert S Krouse; Laurence E McCahill; Alexandra M Easson; Geoffrey P Dunn
Journal:  J Am Coll Surg       Date:  2002-07       Impact factor: 6.113

3.  Are hospices ready to participate in palliative care research? Results of a national survey.

Authors:  David J Casarett; Jason Karlawish; Karen B Hirschman
Journal:  J Palliat Med       Date:  2002-06       Impact factor: 2.947

4.  Ethical considerations and barriers to research in surgical palliative care.

Authors:  Robert S Krouse; Alexandra M Easson; Peter Angelos
Journal:  J Am Coll Surg       Date:  2003-03       Impact factor: 6.113

Review 5.  How to use octreotide for malignant bowel obstruction.

Authors:  Carla Ripamonti; Sebastiano Mercadante
Journal:  J Support Oncol       Date:  2004 Jul-Aug

6.  Palliative care research: issues and opportunities.

Authors:  Robert S Krouse; Kenneth E Rosenfeld; Marcia Grant; Noreen Aziz; Ira Byock; Jeffrey Sloan; David Casarett
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2004-03       Impact factor: 4.254

7.  Cancer care during the last phase of life.

Authors: 
Journal:  J Clin Oncol       Date:  1998-05       Impact factor: 44.544

8.  Symptom control in terminally ill patients with malignant bowel obstruction (MBO).

Authors:  R L Fainsinger; K Spachynski; J Hanson; E Bruera
Journal:  J Pain Symptom Manage       Date:  1994-01       Impact factor: 3.612

9.  Equipoise and the ethics of clinical research.

Authors:  B Freedman
Journal:  N Engl J Med       Date:  1987-07-16       Impact factor: 91.245

Review 10.  Research agenda for developing measures to examine quality of care and quality of life of patients diagnosed with life-limiting illness.

Authors:  J M Teno; I Byock; M J Field
Journal:  J Pain Symptom Manage       Date:  1999-02       Impact factor: 3.612

View more
  5 in total

Review 1.  2016 Updated MASCC/ESMO consensus recommendations: Management of nausea and vomiting in advanced cancer.

Authors:  Declan Walsh; Mellar Davis; Carla Ripamonti; Eduardo Bruera; Andrew Davies; Alex Molassiotis
Journal:  Support Care Cancer       Date:  2016-08-17       Impact factor: 3.603

2.  Reducing gastric secretions--a role for histamine 2 antagonists or proton pump inhibitors in malignant bowel obstruction?

Authors:  K Clark; L Lam; D Currow
Journal:  Support Care Cancer       Date:  2009-03-17       Impact factor: 3.603

Review 3.  Surgical management of malignant bowel obstruction: strategies toward palliation of patients with advanced cancer.

Authors:  Robert DeBernardo
Journal:  Curr Oncol Rep       Date:  2009-07       Impact factor: 5.075

Review 4.  MDCT of abdominopelvic oncologic emergencies.

Authors:  Sree Harsha Tirumani; Vijayanadh Ojili; Gowthaman Gunabushanam; Kedar N Chintapalli; John G Ryan; Caroline Reinhold
Journal:  Cancer Imaging       Date:  2013-07-22       Impact factor: 3.909

5.  Nothing to lose: a grounded theory study of patients' and healthcare professionals' perspectives of being involved in the consent process for oncology trials with non-curative intent.

Authors:  Mary Murphy; Eilís McCaughan; Matthew A Carson; Monica Donovan; Richard H Wilson; Donna Fitzsimons
Journal:  BMC Palliat Care       Date:  2020-10-30       Impact factor: 3.234

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.